Merck EPS - Earnings per Share 2010-2025 | MRK

Merck earnings per share (EPS) for the twelve months ending March 31, 2025 was $6.88, a 664.44% increase year-over-year.

  • Merck EPS for the quarter ending March 31, 2025 was $2.01, a 7.49% increase year-over-year.
  • Merck 2024 annual EPS was $6.74, a 4714.29% increase from 2023.
  • Merck 2023 annual EPS was $0.14, a 97.55% decline from 2022.
  • Merck 2022 annual EPS was $5.71, a 11.09% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Merck EPS - Earnings per Share 2010-2025 | MRK

  • Merck EPS for the quarter ending March 31, 2025 was $2.01, a 7.49% increase year-over-year.
  • Merck 2024 annual EPS was $6.74, a 4714.29% increase from 2023.
  • Merck 2023 annual EPS was $0.14, a 97.55% decline from 2022.
  • Merck 2022 annual EPS was $5.71, a 11.09% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$731.4B
Johnson & Johnson (JNJ)$393.9B
AbbVie (ABBV)$334.3B
Novo Nordisk (NVO)$287.1B
Roche Holding AG (RHHBY)$255.6B
Novartis AG (NVS)$241.3B
Pfizer (PFE)$139.1B
Sanofi (SNY)$118.5B
Bayer (BAYRY)$31.2B
Innoviva (INVA)$1.2B